Atezolizumab,nivolumab,Pembrolizumab,Ipilimumab
merck,roche,bms
['nivo', 'atezo', 'pembro']
 is an excellent discussant. even though atezo and nivo trials negative there could be reasons for that. i think pembro data is very strong and we should still be discussing it with our adjuvant #kidneycancer #esmo22 
A medical oncologist that specializes in and focuses his research on urologic cancers.